SanaCurrents Closing out ChemoCentryx and Rhythm
ChemoCentryx (NASDAQ:CCXI) and Rhythm Pharmaceuticals (NASDAQ:RYTM) released positive but mixed [...]
FDA Approves Biocryst (BCRX) Drug For HAE; Sanacurrents Closing Out Coverage
After the markets closed on Thursday, December 3, BioCryst Pharmaceuticals [...]
Keeping an Eye on ALLO, SYRS, PTGX, AUTL, and IMRA in Light of Biotech Catalysts; Disclosure Updates
Clinical data findings related to five SanaCurrents catalysts will be [...]
SanaCurrents holding BioCryst (BCRX) shares into December 3 PDUFA
The FDA will decide on December 3 whether to approve [...]
SanaCurrents closing out Adverum Biotechnologies (ADVM)
Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its [...]
Adverum catalyst set for Saturday, November 14
Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data [...]
Calliditas’ Shares Soar About 35% After Hitting Catalyst
Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial [...]
FDA Places Partial Clinical Hold on Molecular Templates Trial; SanaCurrents Suspending Coverage
In an earnings release after the market closed on November [...]